Skip to main content
Signal8

CERO THERAPEUTICS HOLDINGS, INC. (CERO)

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc.

OTC:CEROHealthcare
-4.17%$0.0046
Mkt Cap$383K
EV-
Float–
O/S83.31M
VOL105K sh
$ Vol$463
RVOL0.28×
Inst Own-
Net Cash/Sh-
EarningsDec 2 · in 2w
Dilution
FormDescription
10-Q
8-K
8-K
424B3
10-Q
13G/A
Beneficial Ownership Report (Amended)
424B3
8-K
25-NSE
SEC Filing
424B3
8-K
424B3
8-K
424B3
10-Q
424B3
PROSPECTUS SUPPLEMENT
8-K
CURRENT REPORT
424B3
PROSPECTUS SUPPLEMENT
10-K/A
AMENDMENT NO. 1 TO FORM 10-K
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
424B3
PROSPECTUS SUPPLEMENT NO. 8
10-K
ANNUAL REPORT
424B3
PROSPECTUS SUPPLEMENT
8-K
CURRENT REPORT

1-25 of 446

…

Recent SEC filings with analysis

    CERo Therapeutics Holdings, Inc. (CERO) SEC Filings | Signal8